Novel fusion gene for MiT familial translocation renal cell carcinoma and detection primer and application of novel fusion gene
A technology of renal cell carcinoma and fusion gene, applied in the field of medical testing, can solve the problems of long testing period, scarce testing platform, and high sample quality requirements, achieve reliable detection rate, improve detection rate and accuracy, and expand detection range Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] Embodiment 1 is verified for the case of definite diagnosis:
[0025] Through high-throughput sequencing technology, the team of the present invention detected the PRCC-MITF fusion gene in a case whose morphology conformed to the characteristics of MiT family translocation renal cell carcinoma, and found that the gene was composed of PRCC exon 5 and MITF exon 4 Fusion formed. For this case in which a new PRCC exon5-MITF exon4 fusion gene was detected by high-throughput sequencing RNA-seq, the primers we designed were used for verification.
[0026] 1. Extraction of RNA:
[0027] Strictly follow the RNeasy FFPE Kit operating instructions for extraction. ① Dewaxing: dewax the collected slides with xylene, rinse with absolute ethanol, air-dry and scrape off with a scalpel blade and put them into a 1.5ml EP tube; Proteinase K, mix well, enzymatically digest at 56°C for 15min, then at 80°C for 15min, cool on ice; ③add 16μl DNase buffer, then add 10μl DNase I, mix well, le...
Embodiment 2
[0031] Embodiment 2 detects for control group case
[0032] We analyzed 30 well-diagnosed control cases (including 10 cases of clear cell RCC, 5 cases of papillary RCC, 5 cases of chromophobe RCC, 5 cases of TFE3 translocation-associated RCC and 5 cases of TFEB translocation-associated kidney cancer, all of which theoretically do not have MITF gene translocation) were detected using the primer combination of the present invention, and the RNA extraction, reverse transcription PCR and sequencing methods were the same as above.
[0033] Results: No PRCC-MITF fusion gene was detected by using the primer combination designed in the present invention, which proves that the primers designed in this project have high specificity.
[0034] Evaluation: The primer combination of the present invention is a supplement to the original primers of the MiT family translocation renal cell carcinoma fusion gene, which expands the types of the MiT family translocation renal cell carcinoma fusion...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com